J. Manon, Fei ZHENG 2,4 , Anne WOJTUSCISZYN 3 , Florence FORBES 2,4 , Stéphane BONNET 2,4 , Kristina SKAARE 5 , Pierre-Yves BENHAMOU 1, Sandrine LABLANCHE 1 , on behalf of TRIMECO Study Group*

, Diabetes and Nutrition

C. Inria, I. Grenoble, . Ljk, and F. 3. Grenoble,

C. Leti, U. Dtbs, M. Grenoble-alpes, . Campus, F. Grenoble et al., Department of Clinical Trial Surveillance, Direction of Clinical Research and Innovation (S Logerot PharmD), and Cellular Therapy Unit, Laboratory of Fundamental and Applied Bioenergetics Grenoble, vol.1055

J. Prof, K. Bosson, and . Skaare, European Genomic Institute for Diabetes

C. Phd, M. D. Benomar, F. Prof, and M. D. Pattou,

, Prof E Renard MD

M. D. Prof-c-colin, G. G. Phd, and C. Camillo-brault-pharmd, Service de Transplantation, Néphrologie et Immunologie Clinique (Prof E Morelon MD, F Buron MD), and Service d'Urologie et de Chirurgie de la Transplantation

. F-69003, EA 7425 Health Services and Performance Research, Public Health Service and Health Economic Evaluation

R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. Neil, 10-year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med, vol.359, issue.15, pp.1577-89, 2008.

W. Group-for-the, D. Group, T. J. Orchard, D. M. Nathan, B. Zinman et al., Association between 7 years of intensive treatment of type 1 diabetes and longterm mortality, JAMA, vol.313, issue.1, pp.45-53, 2015.

I. B. Hirsch, Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does! Diabetes Care, vol.38, pp.1610-1614, 2015.

B. Guerci, Asymptomatic glycemic instability: how to measure it and which clinical applications? Diabetes Metab, vol.29, pp.179-88, 2003.

G. V. Gill, The spectrum of brittle diabetes, J R Soc Med, vol.85, issue.5, pp.259-61, 1992.

P. Y. Benhamou, L. Milliat-guittard, A. Wojtusciszyn, L. Kessler, C. Toso et al., Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials, Diabet Med J Br Diabet Assoc, vol.26, issue.6, pp.617-638, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00438784

L. A. Kent, G. V. Gill, and G. Williams, Mortality and outcome of patients with brittle diabetes and recurrent ketoacidosis, Lancet Lond Engl, vol.344, issue.8925, pp.778-81, 1994.

Y. Saisho, Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?, Int J Mol Sci, vol.15, issue.10, pp.18381-406, 2014.

D. Rodbard, New and improved methods to characterize glycemic variability using continuous glucose monitoring, Diabetes Technol Ther, vol.11, issue.9, pp.551-65, 2009.

C. Fabris, A. Facchinetti, G. Sparacino, M. Zanon, S. Guerra et al., Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis, Diabetes Technol Ther, vol.16, issue.10, pp.644-52, 2014.

G. Scheiner, CGM Retrospective Data Analysis, Diabetes Technol Ther, vol.18, issue.2, pp.2-14, 2016.

F. J. Service, G. D. Molnar, J. W. Rosevear, E. Ackerman, L. C. Gatewood et al., Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability, Diabetes, vol.19, issue.9, pp.644-55, 1970.

T. A. Peyser, A. K. Balo, B. A. Buckingham, I. B. Hirsch, and A. Garcia, Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data, Diabetes Technol Ther, vol.20, issue.1, pp.6-16, 2018.

A. Wojtusciszyn, J. Branchereau, L. Esposito, L. Badet, F. Buron et al., Société francaise d'endocrinologie (SFE), Société francophone de transplantation (SFT) and Société française de néphrologie - dialyse -transplantation (SFNDT), Statement of the TREPID working group on behalf of the Société francophone du diabète (SFD), 2018.

E. A. Ryan, B. W. Paty, P. A. Senior, J. Lakey, D. Bigam et al., Beta-score: an assessment of betacell function after islet transplantation. Diabetes Care, vol.28, pp.343-350, 2005.

M. R. Rickels, P. G. Stock, E. De-koning, L. Piemonti, J. Pratschke et al., Defining Outcomes for ?-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop, Transplantation, vol.102, issue.9, pp.1479-86, 2018.

S. Lablanche, M. Vantyghem, L. Kessler, A. Wojtusciszyn, S. Borot et al., Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial, Lancet Diabetes Endocrinol, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02003825

I. B. Hirsch, Glycemic variability: it's not just about A1C anymore! Diabetes Technol Ther, vol.7, pp.780-783, 2005.

A. Ceriello, L. Monnier, and D. Owens, Glycaemic variability in diabetes: clinical and therapeutic implications, Lancet Diabetes Endocrinol, 2018.

D. Rodbard, Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control, Diabetes Technol Ther, vol.11, issue.1, pp.55-67, 2009.

K. M. Miller, N. C. Foster, R. W. Beck, R. M. Bergenstal, S. N. Dubose et al., Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care, vol.38, pp.971-979, 2015.

, CITR 9th Annual Report | CITR, 2018.

L. Monnier, C. Colette, A. Wojtusciszyn, S. Dejager, R. E. Molinari et al., Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes, Diabetes Care, vol.40, issue.7, pp.832-840, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01821327

G. Su, S. Mi, H. Tao, Z. Li, H. Yang et al., Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care, vol.36, pp.1026-1058, 2013.

M. Vantyghem, V. Raverdy, A. Balavoine, F. Defrance, R. Caiazzo et al., Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (?score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (?-score greater than 3), J Clin Endocrinol Metab, vol.97, issue.11, pp.2078-2083, 2012.

L. Kessler, R. Passemard, J. Oberholzer, P. Y. Benhamou, P. Bucher et al., Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring. Diabetes Care, vol.25, pp.2256-62, 2002.

E. A. Ryan, J. R. Lakey, R. V. Rajotte, G. S. Korbutt, T. Kin et al., Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol, Diabetes, vol.50, issue.4, pp.710-719, 2001.

A. M. Brooks, R. Oram, P. Home, N. Steen, and J. Shaw, Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation. Diabetes Care, vol.38, pp.105-117, 2015.

M. C. Geiger, J. V. Ferreira, M. M. Hafiz, T. Froud, D. A. Baidal et al., Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation, Cell Transplant, vol.14, issue.2-3, pp.77-84, 2005.

J. Zhou, H. Li, X. Ran, W. Yang, Q. Li et al., Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring, Med Sci Monit Int Med J Exp Clin Res, vol.17, issue.1, pp.9-13, 2011.

N. R. Hill, N. S. Oliver, P. Choudhary, J. C. Levy, P. Hindmarsh et al., Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups, Diabetes Technol Ther, vol.13, issue.9, pp.921-929, 2011.

M. Reddy, I. F. Godsland, K. D. Barnard, P. Herrero, P. Georgiou et al., Glycemic Variability and Its Impact on Quality of Life in Adults With Type 1 Diabetes, J Diabetes Sci Technol, vol.10, issue.1, pp.60-66, 2015.

S. E. Siegelaar, E. S. Kilpatrick, A. S. Rigby, S. L. Atkin, J. Hoekstra et al., Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT, Diabetologia, vol.52, issue.10, pp.2229-2261, 2009.

P. Y. Benhamou, F. Somers, S. Lablanche, I. Debaty, A. L. Borel et al., Impact of flexible insulin therapy on blood glucose variability, oxidative stress and inflammation in type 1 diabetic patients: the VARIAFIT study, Diabetes Metab, vol.40, issue.4, pp.278-83, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01929290

D. Rodbard, Clinical interpretation of indices of quality of glycemic control and glycemic variability, Postgrad Med, vol.123, issue.4, pp.107-125, 2011.

L. Crenier, M. Lytrivi, A. Van-dalem, B. Keymeulen, and B. Corvilain, Glucose Complexity Estimates Insulin Resistance in Either Nondiabetic Individuals or in Type 1 Diabetes, J Clin Endocrinol Metab, vol.101, issue.4, pp.1490-1497, 2016.

M. Hanefeld, C. Koehler, C. Hoffmann, K. Wilhelm, W. Kamke et al., Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes, Diabet Med J Br Diabet Assoc, vol.27, issue.2, pp.175-80, 2010.

F. Gude, P. Díaz-vidal, C. Rúa-pérez, A. , M. Fernández-merino et al., Glycemic Variability and Its Association With Demographics and Lifestyles in a General Adult Population, J Diabetes Sci Technol, vol.11, issue.4, pp.780-90, 2017.

L. A. Fox, R. W. Beck, and D. Xing, Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabetes Care, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, vol.33, pp.1297-1306, 2010.

T. Danne, R. Nimri, T. Battelino, R. M. Bergenstal, K. L. Close et al., International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care, vol.40, pp.1631-1671, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01742117

R. M. Bergenstal, A. J. Ahmann, T. Bailey, R. W. Beck, J. Bissen et al., Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile, J Diabetes Sci Technol, vol.7, issue.2, pp.562-78, 2013.

G. Le-cerveau-de-la-bande, après toutes ces années je ne sais toujours pas si je devrais vraiment mais je te voue une entière confiance dans l'organisation de nos virées collectives? Merci de garder une motivation à toute épreuve et de répondre toujours présent

M. Kiki, y'aurait tellement à dire que c'en est simple : restes comme tu es c'est génial ! Entre tes cris de joie, des crises de panique, ton calme à presque toute épreuve, ton énergie débordante, tous plus ou moins justifiés

. Guigui, tu incarnes pour moi à la fois la bohème et le grand Professeur de neuroloGUI ! J'ai plein de respect pour ton calme, ta tolérance et tes grands projets

C. Toto, Hé mais c'est les Aymard !) Vous formez un si joli couple chacun avec votre grain de folie, Toto avec ton humour et ton côté un peu maniaque et Claire avec ton sourire constant et ton côté hippie chic?

, Et les nouveaux arrivants : Flo, merci d'avoir survécu aux premiers temps (on en revient aux crises de panique plus ou moins justifiées héhé), tu as bien mérité ta place

, Celles qui étaient là dès le début de ces longues années d'étude, avec qui j'en ai fêté une partie à travers le Pérou la Bolivie et le Chili, et avec qui j'ai toujours un énorme plaisir à passer du temps

, Mon Yaya, mon chercheur fou, merci pour les pâtes au citron, et pour ton air concentré capable de muter en une seconde en un rire d'enfant. Merci pour ces moments, on se marre tellement avec toi

M. Lisa and . Foufou,

. Martinus, tu es parti bien loin dans tes contrées Nancéennes mais c'était pour la bonne cause ! Tu as trouvé encore une fois le bon équilibre

L. Vinou, est toujours un plaisir de retrouver vos sourires dans les Landes ou pendant les weekends ski. Merci pour l'accueil en Gwada et surtout? vive la Planté-Cup !

, Aux autres copains qui font des Landes et des autres retrouvailles des moments géniaux : Lexou, Momo, Hadri? Et à Paulo, mon jumeau de thèse ! Félicitations Dr Deschamps !